Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Use of 78c or pharmaceutical composition thereof in preparing anti-rheumatoid arthritis product

A rheumatoid, composition technology, applied in the field of biomedicine, can solve the problems of aggravating the burden on patients' kidneys and economic burden

Pending Publication Date: 2022-01-07
THE AFFILIATED HOSPITAL OF QINGDAO UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Among the existing drugs for the treatment of rheumatoid arthritis, it is difficult for a single drug to improve the immune system and inflammatory symptoms at the same time, and the combined drug will increase the burden on the patient's kidneys and economic burden.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of 78c or pharmaceutical composition thereof in preparing anti-rheumatoid arthritis product
  • Use of 78c or pharmaceutical composition thereof in preparing anti-rheumatoid arthritis product
  • Use of 78c or pharmaceutical composition thereof in preparing anti-rheumatoid arthritis product

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] 1. Materials and methods

[0048] 1. Materials

[0049] 1.1 Experimental animals

[0050] 6-week-old c57BL / 6JNifdc male mice were purchased from Beijing Weitong Lihua Experimental Animal Technology Co., Ltd., and the feeding and operation of experimental animals were carried out in accordance with the Helsinki Convention on Animal Protection and the Regulations of the People's Republic of China on the Administration of Experimental Animals.

[0051] 1.2 Clinical specimens

[0052] The peripheral blood samples (n=30) of healthy volunteers collected in this study came from the Physical Examination Center of the Affiliated Hospital of Qingdao University. The sample collection and experimental design were approved by the Ethics Committee of the Affiliated Hospital of Qingdao University, and all patients gave written informed consent.

[0053] 2. Method

[0054] 2.1 78c treatment of collagen-induced arthritis mouse model

[0055] 24 mice were randomly divided into two gr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to use of 78c or a pharmaceutical composition thereof in preparaing an anti-rheumatoid arthritis product. The technical purpose of the invention is to provide a novel rheumatoid arthritis treatment medicine which can simultaneously regulate immune function and relieve inflammatory symptom. A research proves that the compound 78c can effectively relieve a toe swelling degree of a CIA mouse, recover immune balance, reduce concentration of leukocytes, neutrophils, lymphocytes, hemoglobin, platelets, IFN-gamma, IL-6, IL-12p70, IL-17A, IL-27 and TNF-alpha in peripheral blood of the mouse, relieve the inflammatory symptom of a disease model, and can be used as a potential therapeutic drug for rheumatoid arthritis.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and specifically relates to the application of compound 78c in the preparation of anti-rheumatoid arthritis therapeutic drugs. Background technique [0002] The information disclosed in this background section is only intended to increase the understanding of the general background of the present invention, and is not necessarily taken as an acknowledgment or any form of suggestion that the information constitutes the prior art already known to those skilled in the art. [0003] Rheumatoid arthritis (RA) is an autoimmune disease characterized by erosive arthritis. It is a chronic systemic disease of unknown etiology mainly characterized by inflammatory synovitis. The current medications are non-steroidal anti-inflammatory drugs (NSAIDS) and disease-modifying antirheumatic drugs (DMARDs), which include biological agents in addition to classic gold preparations, chloroquine, penicillamine, and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/4709A61K45/06A61P19/02A61P29/00A61P37/02A23L33/10
CPCA61K31/4709A61K45/06A61P19/02A61P29/00A61P37/02A23L33/10A23V2002/00A61K2300/00A23V2200/30
Inventor 常晓天
Owner THE AFFILIATED HOSPITAL OF QINGDAO UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com